This morning, on Tues., Sept. 13, President Andrés Manuel López Obrador announced in a conference that 3 pre-purchase agreements for Covid-19 vaccinations were signed, guaranteeing access to the vaccine for 107 to 116 million Mexicans.
Pfizer, AztraZenca and CanSino were the pharmaceutical companies with which the agreement was signed, said Marcelo Ebrard, Secretary of Foreign Relations.
According to data cited by Ebrard, the pharmaceutical company CanSino will provide 35 million vaccinations, AztraZeneca 38.7 million, and Pfizer will deliver around 17.2 million.
Ebrard also mentioned Mexico’s participation in the World Health Organization or WHO Covax program through which 20 percent of the Mexican population is expected to be vaccinated. Added to the vaccines purchased from the pharmaceutical companies, this would total an expected coverage of 116 million doses.
According to the agreement with the pharmaceutical companies, the doses are expected to arrive in Mexico in the month of December and through the course of 2021. “We will not be left behind compared to other countries,” stated President Obrador, expressing his desire for Mexico to be one one of the first countries to obtain the Covid-19 vaccine.
For his part, the Secretary of the Treasury, Arturo Herrera, said that the total purchase of the doses will amount to USD$1.659 million, equivalent to $35.153 million Mexican pesos.
President Obrador announced that he will meet with the Secretary of Health, Dr. Jorge Alcocer, as well as Ebrard and Herrera to discuss how to move forward with the logistics.